Related Experiment Video
Updated: Apr 27, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Hemotherapy algorithms for coagulopathic cardiac surgery patients
New hemotherapy algorithms for cardiac surgery patients aim to reduce allogeneic blood transfusions. These practical algorithms utilize either Point-of-Care (POC) testing or conventional coagulation tests for improved patient outcomes.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Transfusion Medicine
- Clinical Coagulation
Background:
- Perioperative coagulopathy and allogeneic blood product use in cardiac surgery correlate with increased mortality and adverse events.
- Current hemotherapy practices often rely on clinical judgment, lacking standardized algorithms.
- A debate exists regarding the optimal basis for hemotherapy: conventional laboratory tests versus Point-of-Care (POC) measures.
Purpose of the Study:
- To develop and present practical hemotherapy algorithms for cardiac surgery.
- To compare algorithms based on POC measures versus conventional coagulation testing.
- To address the complexity of existing hemotherapy algorithms and facilitate daily practice integration.
Main Methods:
- Development of two comprehensive and practical hemotherapy algorithms in collaboration with three German University Hospitals.
- Algorithms are designed for implementation using either POC measures or conventional coagulation testing.
- The structure and limitations of the developed algorithms are presented and discussed.
Main Results:
- Evidence supports viscoelastic and aggregometric measurements in reducing allogeneic blood product transfusion rates.
- Data suggest that improved clinical outcomes are associated with these advanced hemostatic therapy measures.
- The newly developed algorithms offer a more practical approach compared to existing complex hemotherapy protocols.
Conclusions:
- Practical hemotherapy algorithms, based on either POC or conventional testing, can be implemented in clinical practice.
- These algorithms aim to optimize hemostatic therapy and potentially reduce allogeneic blood product use in cardiac surgery.
- Further discussion on the structure and limitations is provided to guide clinical adoption.
More Related Videos
06:22Author Spotlight: Advancing Cardiovascular Research — Tailored Langendorff Perfusion Techniques for Improved Experimental Outcomes
Published on: June 14, 2024
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Venous Thrombosis IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management